DEFEAT-COVID Trial

COVID drug study testing clinical effectiveness and safety of leflunomide when added to standard clinical care

[DEFEAT-COVID Trial @CovidTrial]

@ISARIC1 @FinancialTimes Amazing improvement.

We hope that with positive results from drug trials like ours, @CovidTrial - looking to see if leflunomide, a drug used in rheumatoid arthritis improves outcomes, helps the survival rate get even better.

[DEFEAT-COVID Trial @CovidTrial]

@LSHTM @PHE_uk At Ashford and St Peters Hospital NHS Trust, were doing our bit by running a new drug trial in medium to critical COVID patients who are hospitalised. We are looking to open new sites so contact [email protected] or [email protected] for info
@CovidTrial

[DEFEAT-COVID Trial @CovidTrial]

Welcome to the DEFEAT-COVID clinical trial.

We are trying to establish if leflunomide, used for rheumatoid arthritis, is clinically effective against COVID infection.

We are looking to open new sites; contact [email protected] or [email protected] for info.